Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign ...

Picking the Right Patient for Human Epidermal Growth Factor Receptor 3–Targeted Therapy in Platinum-Resistant Ovarian Cancer The Oncology Grand Rounds series is designed to place original reports ...

A number of studies have reported an increased incidence of hypothalamic–pituitary dysfunction following traumatic brain injury or subarachnoid hemorrhage, and infections of the central nervous system ...

Please provide your email address to receive an email when new articles are posted on . In May, the Endocrine Society issued a clinical practice guideline for diagnosing and treating functional ...

This is due to epigenetic components: microRNA, histone and DNA methylation, gene mutations that alter the expression and production of the neurotrophic factor BDNF, which interacts with the receptors ...

Craniopharyngioma (CP), although histologically benign, is a surgically challenging sellar-region tumor for which stereotactic irradiation is increasingly used as an alternative or adjuvant strategy.